EUVIMEDEUVIMED entdecken
Crossref

Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper

Anzhela Soloveva iD, Jin Joo Park, Efstratios A Apostolou, Michael Böhm iD, Antonio Cannata iD, Marat Fudim, Veraprapas Kittipibul, Sebastian Mueller, Ksenia Potapova, Jörn M Schattenberg iD, Erzhan Suleimenov, Olga I Tarasova und 5 weitere

European Journal of Heart Failure · 31.07.2026

DOI: 10.1093/ejhf/xuag243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 31.07.2026. Verfasst von Anzhela Soloveva und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Therapy Department №2, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation. Die Arbeit nennt 235 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) and chronic liver disease account for substantial morbidity and mortality worldwide. Both conditions share common risk factors and a bidirectional pathophysiology, and the coexistence of both conditions is expected to increase over time. Management of coexisting HF and liver disease is challenged by the under-representation of participants with liver disease in landmark HF clinical trials, impaired haemodynamics at advanced stages of liver disease, altered drug metabolism, and higher risk of adverse events than portended by either condition alone. Moreover, diagnostic pitfalls might be encountered in relation to assessing the primary aetiologies driving the disease process, estimating the degree of liver fibrosis, and differentiating primary liver disease from HF-related liver congestion particularly, given the complex interplay between sinusoidal pressure, congestion, and structural fibrosis. Cardiovascular-hepatic cross-thematic research, clinical education, and health care services could optimize management and patient outcomes. The purpose of the current review is to (i) highlight the growing epidemiology of concurrent HF-liver disease; (ii) provide diagnostic clues for liver disease and an approach for interpreting liver marker abnormalities amongst HF patients; (iii) describe the main therapeutic strategies in real-world clinical settings; and (iv) discuss current gaps in knowledge and future directions. This update on the framework of the HF-liver disease overlap phenomenon can inform clinical care policies and facilitate novel research in the field.

Schlagwörter

Stichwörter der Autor:innen

heart failureliver cirrhosisliver diseasemetabolic dysfunction-associated steatotic liver diseasetherapy

Autor:innen und Institutionen

  • Hospital Therapy Department №2, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
  • Cardiovascular Center, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University School of Medicine, Seongnam, Republic of Korea.
  • Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Medical Technology Research Group and Department of Health Policy, LSE Health, London School of Economics and Political Science, London, United Kingdom.
  • Department of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Homburg, Germany.
  • Department of Cardiology, King's College Hospital and School of Cardiovascular Medicine & Sciences, King's College London, London, United Kingdom.

ORCID-Profile: Anzhela Soloveva, Michael Böhm, Antonio Cannata, Jörn M Schattenberg, Harriette G C Van Spall, Amina Rakisheva

Zitieren

APA

Soloveva, A., Park, J. J., Apostolou, E. A., Böhm, M., Cannata, A., Fudim, M., Kittipibul, V., Mueller, S., Potapova, K., Schattenberg, J. M., Suleimenov, E., Tarasova, O. I., Tun, H. N., Van Spall, H. G. C., Wu, H. H. L., Zykin, B., & Rakisheva, A. (2026). Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag243

Vancouver

Soloveva A, Park JJ, Apostolou EA, Böhm M, Cannata A, Fudim M, et al. Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper. European Journal of Heart Failure. 2026. doi:10.1093/ejhf/xuag243

BibTeX
@article{Soloveva2026,
  author = {Soloveva, Anzhela and Park, Jin Joo and Apostolou, Efstratios A and Böhm, Michael and Cannata, Antonio and Fudim, Marat and Kittipibul, Veraprapas and Mueller, Sebastian and Potapova, Ksenia and Schattenberg, Jörn M and Suleimenov, Erzhan and Tarasova, Olga I and Tun, Han Naung and Van Spall, Harriette G C and Wu, Henry H L and Zykin, Boris and Rakisheva, Amina},
  title = {Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper},
  journal = {European Journal of Heart Failure},
  year = {2026},
  doi = {10.1093/ejhf/xuag243}
}
Kostenlos starten →